engleski

Higher expressions of SHH and AR are associated with a positive receptor status and have impact on survival in a cohort of Croatian breast cancer patients

Breast cancers (BC) are usually classified into four molecular subtypes according to the expression of estrogen (ER), progesterone (PR), and human epidermal growth factor 2 (HER2) receptors and proliferation marker Ki‐67. Despite available anti‐hormonal therapies and due to the inherent propensity of some subtypes to develop metastasis, there is a permanent need to discover new prognostic and predictive biomarkers, as well as therapeutic targets for BC. In this study, we used immunohistochemical staining to determine the expression of androgen receptor (AR) and sonic hedgehog protein (SHH), the main ligand of the Hedgehog‐GLI (HH‐GLI) signaling pathway, in 185 archival primary BC tissue samples and correlated it with clinicopathological characteristics, molecular subtypes, receptors statuses, and survival in a cohort of Croatian BC patients. Results showed that higher SHH and AR expressions were associated with positive receptor status, but increased SHH expression had a negative impact on survival in receptor‐negative BCs. On the contrary, higher AR expression was mostly protective. However, multivariate analysis showed that only higher AR expression could be considered as an independent prognostic biomarker for poorer overall survival in triple‐negative breast cancer patients (TNBC) (HR 10.9, 95% CI 1.43–83.67 ; p = 0.021), what could be Croatian population‐related. SHH could be a potential target for treating TNBCs and HER2‐enriched BCs, in cases where HH‐GLI signaling is canonical (SHH‐ dependent).

breast cancer ; molecular subtypes ; sonic hedgehog protein ; androgen receptor ; prognostic biomarkers ; survival analysis

nije evidentirano